Many areas of the global spine device market are expected to grow in the coming years, researchers are anticipating.
Global spine device market
From a Future Marketing Insights report
1. The spine device market was valued at $13.1 billion in 2022, and it is projected to reach $21.96 billion in 2032.
2. The market is expected to grow at a compound annual growth rate of 5.3% between 2022 to 2032.
3. Spinal cord injuries have increased in recent years because of an increase in sedentary lifestyles, driving market growth.
4. Other factors driving market growth include increased use of spinal devices in older patients and patients with arthritis.
5. Therapeutics and ongoing drug research for surgery pain could hinder the growth of the spinal device market.
6. Hospitals are expected to have the highest market share in the global market for spine devices from 2016 to 2026.
7. North America holds the largest market for spine devices, and the availability of new technologies in the region will boost growth.
8. The Asia Pacific region is projected to be the fastest growing market from 2022 to 2032 as governments are increasing investment in developing healthcare infrastructure.
9. Key players in the spinal device market include Stryker, Vertiflex, RTI Surgical, Orthofix, Medtronic and CONMED.
Minimally invasive spine technology market
From a Mordor Intelligence report
10. The minimally invasive spine market is projected to grow at a CAGR of 5.5% from 2021 to 2029.
11. The COVID-19 pandemic affected the minimally invasive spine surgery market after elective cases were canceled early on.
12. Market growth is driven by the increase of spinal disorders, rising number of ASCs and increase in the aging and obese populations.
13. Advancements in surgical technology and increasing product approvals and partnerships are helping with the minimally invasive market growth.
14. However regulatory frameworks and high procedure costs could impede market growth.
15. Major players include Johnson & Johnson, Zimmer Biomet, Medtronic, Boston Scientific and Sesculap.
16. The biomaterial segment is projected to see growth in the minimally invasive spine market. They play a role in developing devices and implants to support the spine and enhance healing.
17. North America is expected to see significant growth in the minimally invasive spine market.
Spinal non-fusion device market
From a Global Data report
18. The spinal non-fusion market is expected to grow at a CAGR of more than 5% from 2023 to 2033.
19. In 2023, the spinal non-fusion market was $884.8 million.
20. Spinal non-fusion surgery is used to treat conditions including spinal instability, degenerative disc disorder, and spinal stenosis while preserving the spine's natural motion.
21. Key segments in the spinal non-fusion market include annulus repair devices, artificial disc replacement systems, facet arthroplasty devices, interspinous process decompression devices and pedicle screw-based dynamic stabilization systems.
22. Market researchers expect a promising future for spinal non-fusion as more spine surgeons are adopting motion-preserving techniques.
23. Disc replacement accounted for the highest market share in 2023.
24. The U.S., Canada and Mexico are expected to see strong growth in volume of spinal non-fusion surgeries from 2023 to 2033.
25. Leading companies in spinal non-fusion include Medtronic, Globus Medical, Centinel Spine, Paradigm Spine and ZimVie (now Highridge Medical). Medtronic dominated the spinal non-fusion market in 2023.
Surgical navigation systems market
From a Grand View Research report
26. The global surgical navigation system market was valued at $8 billion in 2022 and is expected to grow at a CAGR of 14.2% to 2030.
27. Rising prevalence of osteoarthritis, brain cancer and ENT disorders and a growing aging population are expected to fuel market growth.
28. Another factor contributing to market growth is increased demand for minimally invasive surgeries. Minimally invasive procedures can improve patient recovery and are more economically viable.
29. Hospitals hold the largest share of the market in 2022, but ASCs are expected to see exponential growth.
30. The neurology segment holds the largest share of the surgical navigation market. In 2022, it held 36.6% of the market share.
31. North America had the largest revenue share of the market with 40.6% in 2022.
32. Key companies in the surgical navigation market include DePuy Synthes, Stryker, Zimmer Biomet, Medtronic and Smith+Nephew.
33. The COVID-19 pandemic and subsequent restrictions on elective procedures affected market growth. But factors such as the demand for better patient outcomes and more novel technologies are expected to support market growth.
Orthobiologics market
From a Market.Us report
34. In 2023, the orthobiologics market was $7.9 billion.
35. The orthobiologics market is expected to be worth $14.2 billion by 2033, growing at a CAGR of 6%.
36. The viscosupplement segment had the largest market share in 2023.
37. Key factors of market growth include a growing number of orthopedic injuries, an increased aging population and favorable medical reimbursement policies for orthobiologics.
38. Two key developments in the orthobiologics market are the introduction of the NorthStar cervical and Flash navigation lumbar facet fusion orthobiologics systems and the launch of the first injectable bone void filler.
39. Spinal fusions hold a market share of 72.9% in orthobiologics.
40. Hospitals and ASCs play a significant role in uplifting the orthobiologics.
41. North America leads the orthobiologics, and the Asia Pacific region has the fastest growing market.
Bone graft market
From a Precedence Research report
42. The bone grafts and substitutes market accounted for $3.2 billion in 2025.
43. The market is expected to grow to $3.38 billion in 2025 and then about $4.22 billion by 2029.
44. The allograft segment is expected to dominate the bone graft market. They can be used for a variety of spine and orthopedic surgeries, and medtech companies have launched more allograft products in recent years.
45. North America has the strongest reach in the global bone grafts market holding 47.7% of it in 2023.
46. The Asia Pacific region is expected to see the fastest growth between 2023 and 2032 with a CAGR of 6.4%.
47. Spinal fusions were the most common application in the bone grafts market, taking up 52.2% of the market share in 2023. About 300,000 lumbar spinal fusions are performed each year.
48. The trauma fixation segment is expected to see the fastest growth with a CAGR of 6.1%.
49. North America's bone grafts market size was $1.4 million in 2023 and is expected to reach $2.4 billion by 2032.
50. The European market surpassed $733.2 million in 2023 and is expected to grow at a CAGR of 6% from 2023 to 2032.